Healthy Clinical Trial
Official title:
High-Intensity Functional Training Adaptations With and Without Maximus Ventilatory Training Device
This project aims to assess the effectiveness of using a Respiratory Muscle Training (RMT) device during high-intensity functional training (HIFT) to improve fitness and ventilatory parameters. Primary outcome measures include aerobic, anaerobic, and HIFT measures. Secondary measures include sleep, affect, and mood state questionnaires. Participants will be randomized into one of two groups: with the RMT device and without the RMT device.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | September 1, 2024 |
Est. primary completion date | September 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Males and females between the ages of 18 and 35 (inclusive) who participate in at least 150 minutes per week of physical activity. - Have not participated in HIFT training in the last 6 months. - Provided written and dated informed consent to participate in the study. - In good health as determined by medical history and is cleared for exercise. - Participant will be asked about dietary supplementation use within the past 6 months. - If participant began taking a supplement within the past month, subject will be asked to discontinue supplement use followed by a 2-week washout prior to participation. - In all other cases, we will request that participant maintain supplement use. Exclusion Criteria: - Any musculoskeletal injuries that would prevent exercising. - Any metabolic disorder including known electrolyte abnormalities, diabetes, uncontrolled thyroid disease, adrenal disease or hypogonadism. - Any inborn error of metabolism. - History of hepatorenal, musculoskeletal, autoimmune, or neurologic disease. - Participants with a personal history of heart disease, high blood pressure (systolic >140 mm Hg & diastolic >90 mm Hg), - Participants who are pregnant, planning to become pregnant, or lactating. |
Country | Name | City | State |
---|---|---|---|
United States | University of South Carolina Sport Science Lab | Columbia | South Carolina |
Lead Sponsor | Collaborator |
---|---|
University of South Carolina | MAXIMUS |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in spirometry | Spirometry measures of forced vital capacity (FVC) (L), forced expiratory volume at one second (FEV1) (L), and the ratio of FEV1/FVC % | Baseline and Week 8 | |
Primary | Changes in aerobic capacity | Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry. | Baseline and Week 8 | |
Primary | Changes in peak power | Assessed via a cycle-ergometer based maximal graded exercise test | Baseline and Week 8 | |
Primary | Changes in ventilatory threshold | Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry. | Baseline and Week 8 | |
Primary | Changes in countermovement jump | Assessed via force plates | Baseline and Week 8 | |
Primary | Changes in anaerobic capacity | Assessed via 30-second Wingate test. | Baseline and Week 8 | |
Primary | Changes in high-intensity functional training test | Assessed via a high-intensity functional training circuit composed of rows, pushups, and squats | Baseline and Week 8 | |
Primary | Changes in heart rate at ventilatory threshold | Assessed via a cycle-ergometer based maximal graded exercise test with indirect calorimetry. | Baseline and Week 8 | |
Secondary | Changes in body composition | Body fat percentage, fat-free mass, and fat mass via air-displacement plethysmography. | Baseline and Week 8 | |
Secondary | Changes in sleep quality | Assessed by Pittsburgh Sleep Quality Index. The minimum score is 0 and the maximum score is 40. Higher scores mean a worse outcome. | Baseline and Weeks 3, 5, and 7 | |
Secondary | Changes in total mood disturbances | Assessed by the Profile of Mood States (POMS). The total mood is calculated by adding the negative subscales (tension, depression, fatigue, confusion, and anger) and subtracting the positive subscales (vigor, esteem-related affect). Minimum score of -36 and max score of 200. Lower scores for total mood disturbance are considered better. | Baseline and Weeks 3, 5, and 7 | |
Secondary | Changes in positive mood and emotion | Assessed by the Positive and Negative Affect Schedule. Min values of 0 and max of 50, higher scores indicate more positive moods and emotions. | Baseline and Weeks 3, 5, and 7 | |
Secondary | Change in blood lactate responses | Biochemical responses to exercise. Blood lactate sampled pre and post exercise during the last training day of the week. | Weeks 3, 5, and 7 | |
Secondary | Changes in negative mood and emotion | Assessed by the Positive and Negative Affect Schedule. Min values of 0 and max of 50, higher scores indicate more negative moods and emotions with lower scores indicating less negative moods and emotions. | Baseline and Weeks 3, 5, and 7. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |